UBS Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-13,084
| Closed | -$236K | – | 7764 |
|
|
2020
Q2 | $236K | Sell |
13,084
-115,527
| -90% | -$2.08M | ﹤0.01% | 3896 |
|
|
2020
Q1 | $917K | Buy |
128,611
+101,924
| +382% | +$727K | ﹤0.01% | 2733 |
|
|
2019
Q4 | $638K | Sell |
26,687
-162,086
| -86% | -$3.87M | ﹤0.01% | 3701 |
|
|
2019
Q3 | $5.06M | Sell |
188,773
-3,942
| -2% | -$106K | ﹤0.01% | 1839 |
|
|
2019
Q2 | $5.23M | Buy |
192,715
+45,910
| +31% | +$1.25M | ﹤0.01% | 1797 |
|
|
2019
Q1 | $5.09M | Sell |
146,805
-188,479
| -56% | -$6.54M | ﹤0.01% | 1758 |
|
|
2018
Q4 | $6.54M | Buy |
335,284
+180,279
| +116% | +$3.52M | ﹤0.01% | 1514 |
|
|
2018
Q3 | $4.13M | Buy |
155,005
+81,342
| +110% | +$2.17M | ﹤0.01% | 2031 |
|
|
2018
Q2 | $2.78M | Sell |
73,663
-73,738
| -50% | -$2.78M | ﹤0.01% | 2290 |
|
|
2018
Q1 | $4.81M | Buy |
147,401
+99,764
| +209% | +$3.26M | ﹤0.01% | 1889 |
|
|
2017
Q4 | $2.32M | Sell |
47,637
-9,878
| -17% | -$481K | ﹤0.01% | 2424 |
|
|
2017
Q3 | $3.11M | Buy |
57,515
+46,768
| +435% | +$2.53M | ﹤0.01% | 2116 |
|
|
2017
Q2 | $603K | Buy |
10,747
+5,990
| +126% | +$336K | ﹤0.01% | 3238 |
|
|
2017
Q1 | $187K | Buy |
4,757
+2,266
| +91% | +$89.1K | ﹤0.01% | 3852 |
|
|
2016
Q4 | $56K | Sell |
2,491
-611
| -20% | -$13.7K | ﹤0.01% | 4829 |
|
|
2016
Q3 | $70K | Sell |
3,102
-30,182
| -91% | -$681K | ﹤0.01% | 4390 |
|
|
2016
Q2 | $786K | Buy |
33,284
+29,771
| +847% | +$703K | ﹤0.01% | 2872 |
|
|
2016
Q1 | $72K | Sell |
3,513
-21,470
| -86% | -$440K | ﹤0.01% | 4446 |
|
|
2015
Q4 | $1.29M | Sell |
24,983
-2,847
| -10% | -$147K | ﹤0.01% | 2514 |
|
|
2015
Q3 | $1.19M | Buy |
27,830
+25,596
| +1,146% | +$1.09M | ﹤0.01% | 2526 |
|
|
2015
Q2 | $101K | Sell |
2,234
-1,441
| -39% | -$65.1K | ﹤0.01% | 4293 |
|
|
2015
Q1 | $139K | Buy |
3,675
+500
| +16% | +$18.9K | ﹤0.01% | 4009 |
|
|
2014
Q4 | $90K | Buy |
+3,175
| New | +$90K | ﹤0.01% | 4301 |
|